Skip to main content
logo
Aurora Cannabis Inc. (ACB)
NASDAQ: ACB · Real-Time Price · USD
3.890
-0.140 (-3.47%)
At close: Sep 3, 2026, 4:00 PM EDT
3.870
-0.020 (-0.51%)
After-hours: Sep 3, 2026, 7:53 PM EDT

Aurora Cannabis Revenue

Aurora Cannabis had revenue of 67.55M CAD in the quarter ending June 30, 2026, a decrease of -8.80%. This brings the company's revenue in the last twelve months to 314.07M, up 12.35% year-over-year. In the fiscal year ending March 31, 2026, Aurora Cannabis had annual revenue of 320.59M with 10.97% growth.

Revenue (ttm)
314.07M CAD
Revenue Growth
+12.35%
P/S Ratio
1.14
Revenue / Employee
305,517 CAD
Employees
1,028
Market Cap
252.62M USD

Revenue Chart

Chart
* This company reports financials in CAD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2026320.59M31.68M10.97%
Mar 31, 2025288.91M19.27M7.15%
Mar 31, 2024269.64M45.83M20.48%
Mar 31, 2023223.80M2.47M1.11%
Jun 30, 2022221.34M-23.91M-9.75%
Jun 30, 2021 Pro Pro Pro
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Emergent BioSolutions770.20M
Organogenesis Holdings457.45M
Akebia Therapeutics219.06M
Organigram Global217.71M
Lifecore Biomedical129.46M
Anika Therapeutics120.65M
ADC Therapeutics79.58M
Journey Medical68.18M
Revenue Rankings

ACB News

More News